Capital Flow Monitor · Sponsors · CIK 2069950
Rythm Health, Inc.
2261 MARKET STREET, SAN FRANCISCO, CA, 94114 · (628) 333-3787
Other Health Care · Corporation· inc. DELAWARE true 2024
Fit score
—
Offering
$31.1M
Sold
$31.1M
% sold
100.0%
Investors
8
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-18 | D ·current | 506(b) | $31.1M | $31.1M | 100.0% | 8 | EDGAR ↗ |
| 2025-11-13 | D | 506(b) | $20.7M | $19.3M | 93.2% | 18 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Robert Wade — Executive Officer / Director / Promoter, San Francisco, CA
- Dacri Burdan — Executive Officer / Director / Promoter, San Francisco, CA
-
Andrew Goletka — Director, San Francisco, CA
2 other raises
- Coefficient Capital Fund II, LP $285.7M of $285.7M · 100.0%
- Magnolia Opportunities LLC Series 4 $6.0M of $6.0M · 100.0%
-
Michael Smith — Director, San Francisco, CA
7 other raises
- Muzinich Corporate Lending Income Fund, Inc. $99.5M of —
- Ares Denali Co-Investment Fund, L.P. $0 of —
- ACIP Apex Co-Investment Feeder II (Cayman), L.P. $11.1M of —
- ACIP Apex Co-Investment II, L.P. $0 of —
- Ares SB Co-Investment Fund II, L.P. $0 of —
- Ares SB Co-Investment Feeder II (Cayman), L.P. $0 of —
- Ares Channelview Acquisition L.P. $0 of —
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.